{
    "eid": "2-s2.0-85166413697",
    "title": "SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis",
    "cover-date": "2023-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "anti-RBD",
        "booster",
        "COVID-19",
        "humoral immunity",
        "infection",
        "SARS-CoV-2",
        "vaccine"
    ],
    "authors": [
        "Ritthideach Yorsaeng",
        "Kamolthip Atsawawaranunt",
        "Nungruthai Suntronwong",
        "Sitthichai Kanokudom",
        "Jira Chansaenroj",
        "Suvichada Assawakosri",
        "Pornjarim Nilyanimit",
        "Ratchadawan Aeemjinda",
        "Nongkanok Khanarat",
        "Lakkhana Wongsrisang",
        "Chompoonut Auphimai",
        "Preeyaporn Vichaiwattana",
        "Sirapa Klinfueng",
        "Thanunrat Thongmee",
        "Donchida Srimuan",
        "Thaksaporn Thatsanathorn",
        "Natthinee Sudhinaraset",
        "Nasamon Wanlapakorn",
        "Yong Poovorawan"
    ],
    "citedby-count": 0,
    "ref-count": 30,
    "ref-list": [
        "Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: A multicentre cohort study",
        "Efficacy and safety of COVID-19 vaccines",
        "Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2",
        "Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status",
        "Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: A retrospective, total population cohort study in Sweden",
        "Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England",
        "COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron",
        "Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: A prospective cohort study",
        "Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults",
        "Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults",
        "Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac",
        "The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine",
        "Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant",
        "mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant",
        "mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines",
        "Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection",
        "COVID-19 vaccine waning and effectiveness and side-effects of boosters: A prospective community study from the ZOE COVID Study",
        "The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5",
        "Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: A cross-sectional survey from October 2022 to January 2023",
        "Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2",
        "Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors",
        "Waning antibodies in SARS-CoV-2 na\u00efve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers",
        "The Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination and Infection on Neutralizing Antibodies: A Nation-wide Cross-sectional Analysis",
        "SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environments",
        "Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010\u20132012",
        "Climate factors influence seasonal influenza activity in Bangkok, Thailand"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "101823394",
            "affilname": "Royal Society of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101823394",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Clinical Virology",
        "Group Aunt Thongkum Foundation",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "National Research Council of Thailand",
        "Health Systems Research Institute"
    ]
}